Founded in 1996 through the merger of Ciba-Geigy and Sandoz, with predecessor roots extending back more than 250 years, Novartis AG is a global innovative medicines company headquartered in Basel, Switzerland. Following the separation of Sandoz, Novartis focuses on innovative medicines and brings together large-scale research, development, manufacturing, and commercial capabilities across major therapeutic areas, with a strategic emphasis on delivering high-value treatments for serious diseases. In 2025, Novartis reported net sales of USD 54.5 billion, employed 75,267 full-time equivalent employees worldwide as of December 31, 2025, and stated that its medicines reached more than 300 million people globally.
Updated 2026-03-19